CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
Neurology Minute · American Academy of Neurology
September 19, 20241m 50s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.
Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496